A Study to Evaluate the Safety, Tolerability, Drug Levels, Food, Formulation, and pH Effects on Relative Absorption of BMS-986465 and Its Active Derivative BMS-986464 in Healthy Participants

NCT06144697 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

267

Enrollment

INDUSTRY

Sponsor class

Stopped Business objectives have changed

Conditions

Healthy Participants

Interventions

DRUG: BMS-986465
OTHER: Placebo
DRUG: Pegasys
DRUG: Famotidine

Sponsor

Bristol-Myers Squibb